Eli Lilly Stock: Analyzing its Valuation and Future PotentialEli Lilly (NYSE: LLY), a pharmaceutical giant with a market cap of $658 billion, has achieved impressive growth in recent years, primarily driven by its diabetes drugs, Mounjaro and Trulicity. But with a current stock price of $732, is Eli Lilly overvalued, or does it present an opportunity for long-term investors? Let’s break down the numbers and evaluate its valuation.